Expression of immune checkpoint molecules programmed death protein 1, programmed death-ligand 1 and inducible T-cell co-stimulator in mycosis fungoides and Sézary syndrome: association with disease stage and clinical outcome.

Di Raimondo, Cosimo; Rubio-Gonzalez, Belen; Palmer, Joycelynne; Weisenburger, Dennis D; Zain, Jasmine; Wu, Xiwei; Han, Zhen; Rosen, Steven T; Song, Joo Y; Querfeld, Christiane

Di Raimondo, Cosimo; Rubio-Gonzalez, Belen; Palmer, Joycelynne; Weisenburger, Dennis D; Zain, Jasmine; Wu, Xiwei; Han, Zhen; Rosen, Steven T; Song, Joo Y; Querfeld, Christiane.

Affiliation

Di Raimondo C; Division of Dermatology.
Rubio-Gonzalez B; Division of Dermatology.
Palmer J; Department of Computational and Quantitative Medicine, Division of Biostatistics.
Weisenburger DD; Department of Pathology.
Zain J; Department of Hematology/Hematopoietic Cell Transplantation.
Wu X; Integrative and Genomics Core.
Han Z; Beckman Research Institute; City of Hope National Medical Center, Duarte, CA, USA.
Rosen ST; Division of Dermatology.
Song JY; Beckman Research Institute; City of Hope National Medical Center, Duarte, CA, USA.
Querfeld C; Department of Hematology/Hematopoietic Cell Transplantation.

Br J Dermatol ; 187(2): 234-243, 2022 08.

Article de En | MEDLINE | ID: mdl-35194801

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs cutanées / Lymphome T cutané / Mycosis fongoïde / Syndrome de Sézary Type d'étude: Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Br J Dermatol Année: 2022 Type de document: Article

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google